In the News January 20, 2016

Bloomberg BNA | Outlook 2016: Lab Tests, Cybersecurity, Off-Label Use Among Top Device Issues

Peter Kazon is quoted on the Food and Drug Administration’s focus to regulate laboratory-developed tests (LDTs) amid uncertainty over the agency’s final LDT guidance.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement